Supporting Promising Cancer Researchers & Lesser Known Causes
What We Do
Offer financial assistance to minimize the costs involved with cancer research and help smaller causes fundraise and promote their mission to a broader community.
Strong team dedicated to helping their friends, colleagues, and family members fight cancer by finding meaningful causes to support and impact directly.
Each year, we choose one researcher, organization or cause and all proceeds from that year's fundraising efforts are dedicated to the selected individual or organization.
At ReMission Foundation, we are dedicated to making a meaningful impact on the fight against cancer by supporting ingenuity in cancer research and by assisting those smaller causes struggling to win the battle. We have funded clinical trials, the purchase of lab and test equipment, and research & database studies. We have also collaborated with lesser known causes to raise awareness for their mission, contribute fundraising and help save lives.
- Provide funding for innovative cancer research programs and studies
- Assist local causes that are dedicated to battling different types of cancer
- Raise awareness for new cancers or causes every year
We are proud to announce for 2019 ReMission Foundation is supporting Carol Shields MD and her retinoblastoma treatment research.
How You Can Participate
Are you interested in getting involved with ReMission Foundation? There are many ways you can help show your support and join the team in the fight against cancer. ReMission Foundation offers many different opportunities for those that want to help:
We have chosen our 2019 cause! With the support of Love From Liam and Eye Tumor Research Foundation, ReMission Foundation is pleased to support Carol Shields MD, Director of the Oncology Service at Wills Eye Hospital & Professor of Ophthalmology at Thomas Jefferson University in Philadelphia, and her retinoblastoma cancer research.
Please check out more information on retinoblastoma cancer and treatment under our News & Noteworthy Section.